We conducted the present study to: (1) assess the status of tumor infiltrating CD1a+ DCs in patients with advanced laryngeal cancer; and (2) to clarify the relationships between CD1a+ DCs and clinicopathological characteristics including outcomes. The gene discussed is CD1A; the disease is laryngeal carcinoma.